Huma Therapeutics

Healthtech · London, GB

AI digital health platform for patient engagement and remote monitoring.

Founders

Dan Vahdat (Iran · ♂) — A Johns Hopkins PhD student from a family of doctors who realized care teams lose all visibility once patients leave the hospital, and founded Huma in 2011 to make medicine proactive and predictive through digital and AI tools.

Shares the most investors with (number = shared investors):

Date	Round	Amount
Jul 2024	Series D Plus Digital-health company Huma Therapeutics closed an $80M Series D with AstraZeneca, Hitachi Ventures and Leaps by Bayer, and launched its Huma Cloud platform.	$80M

Tap an investor to see what else they have backed.

Data is community-curated and may be incomplete.